z-logo
Premium
Postsynaptic density‐95 (PSD95) mediates vasodilator signaling between β1 adrenergic receptor and Shaker ‐type K + (K V 1) channel in rat cerebral arteries
Author(s) -
Moore Christopher L.,
Jang Dae Song,
Parelkar Nikhil K.,
Joseph Biny K.,
Nelson Piper L.,
Kang Eunju,
Rhee Sung W.
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.842.6
Subject(s) - vasodilation , cerebral arteries , postsynaptic potential , vascular smooth muscle , postsynaptic density , vasoconstriction , medicine , cerebral circulation , receptor , microbiology and biotechnology , endocrinology , biophysics , biology , smooth muscle
We recently reported the expression of scaffolding protein postsynaptic density‐95 (PSD95) in the rat cerebral vascular smooth muscle cells (cVSMC). PSD95 binds with the K V 1 channels at the plasma membrane of cVSMC to mediate vasodilation. In this study, we explored whether the beta1 adrenergic receptor (β1AR) expressed in several vascular beds forms a signaling complex with PSD95 in cVSMC. By immunohistochemistry, we observed that β1AR is expressed in rat cVSMC and co‐localizes with PSD95. In pressurized cerebral arteries, isoproterenol‐induced vasodilation (EC 50 ~ 200 nM) was blocked by a selective β1AR blocker, CGP20712 , as well as K V 1 channel blockers, correolide and 5‐(4‐phenylalkoxypsoralen). Next, we designed a membrane‐permeable peptide that mimics the carboxyl‐terminus of K V 1 channels (K V 1‐C) and competes for the binding to PSD95. Application of this K V 1‐C peptide (10 μM) to pressurized arteries caused vasoconstriction and significantly blunted the vasodilation induced by isoproterenol. Interestingly, application of protein kinase inhibitor peptides (PKI, 1 μM) against protein kinase A elicited almost identical responses to those observed with K V 1‐C peptide. Taken together, our study provides initial evidence that β1AR may be another key binding partner of PSD95 in cVSMC, and that PSD95 mediates β1AR‐K V 1 vasodilator signaling pathway in cerebral arteries. Funded by NIH R01 HL097107 (SWR).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom